Activation of dopaminergic D1 receptors promotes morphogenesis of developing striatal neurons

Neuroscience

Volumn 74, Issue 2, 1996, Pages 453-460

  Schmidt, U ^a   Beyer, C ^a   Oestreicher, A B ^b   Reisert, I ^a   Schilling, K ^a   Pilgrim, C ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

c fos; D1 and D2 like receptors; differentiation; dopamine; neuritotrophic action; striatum

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CYCLOHEXIMIDE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; NEUROMODULIN; PROTEIN C FOS; QUINPIROLE; TETRODOTOXIN;

ANIMAL CELL; ARTICLE; BASAL GANGLION; BRAIN DEVELOPMENT; CONTROLLED STUDY; CORPUS STRIATUM; EMBRYO; GENE INDUCTION; GROWTH CONE; MESENCEPHALON; MORPHOGENESIS; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; IMMUNOHISTOCHEMISTRY; SPRAGUE DAWLEY RAT;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; CELLS, CULTURED; CORPUS STRIATUM; IMMUNOHISTOCHEMISTRY; MORPHOGENESIS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1;

EID: 0030225906     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(96)00201-1     Document Type: Article

References (41)

1. Alcantara A.A., Greenough W.T. Developmental regulation of Fos and Fos-related antigens in cerebral cortex, striatum, hippocampus, and cerebellum of the rat. J. comp. Neurol. 334:1993;75-85.
2. Arnauld E., Arsaut J., Tafani J.-A.M., Demotes-Mainard J. Dopaminergic control of gene transcription during striatal ontogeny: c-fos induction by D1 receptor activation in the developing striosomes. Molec. Brain Res. 30:1995;223-232.
3. Beretta S., Robertson H.A., Graybiel A.M. Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum. J. Neurophysiol. 68:1992;767-777.
4. Beyer C., Eusterschulte B., Pilgrim C., Reisert I. Sex steroids do not alter sex differences in tyrosine hydroxylase activity of dopaminergic neurons in vitro. Cell Tissue Res. 270:1992;547-552.
5. Beyer C., Green S.J., Barker P.J., Huskisson N.S., Hutchison J.B. Aromatase-immunoreactivity is localised specifically in neurones in the developing mouse hypothalamus and cortex. Brain Res. 638:1994;203-210.
6. Beyer C., Pilgrim C., Reisert I. Dopamine content and metabolism in mesencephalic and diencephalic cell cultures: sex differences and effects of sex steroids. J. Neurosci. 11:1991;1325-1333.
7. Caboche J., Vernier P., Rogard M., Julien J.-F., Mallet J., Besson M.-J. Role of dopaminergic D2 receptors in the regulation of glutamic acid decarboxylase messenger RNA in the striatum of the rat. Eur. J. Neurosci. 4:1992;438-447.
8. Cruz C.J., Beckstead R.M. Nigrostriatal dopamine neurons are required to maintain basal levels of substance P in the rat substantia nigra. Neuroscience. 30:1989;331-338.
9. Dos Santos Rodrigues P., Dowling J.E. Dopamine induces neurite retraction in retinal horizontal cells via diacylglycerol and protein kinase C. Proc. natn. Acad. Sci. U.S.A. 87:1990;9693-9697.
10. 3H-SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue. Biochem. Pharmac. 38:1989;473-480.
11. Gerfen C.R., McGinty J.F., Young W.S. Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. J. Neurosci. 11:1991;1016-1031.
12. Kerkerian L., Salin P., Nieoullon A. Pharmacological characterization of dopaminergic influence on expression of neuropeptide Y immunoreactivity by rat striatal neurons. Neuroscience. 26:1988;809-817.
13. Kolbinger W., Warchol W. An inexpensive computer-aided morphometric device for the analysis of dissociated brain cell cultures. Comput. Meth. Programs Biomed. 40:1993;3-6.
14. Lankford K.L., DeMello F.G., Klein W.L. D1-type dopamine receptors inhibit growth cone motility in cultured retina neurons: evidence that neurotransmitters act as morphogenetic growth regulators in the developing central nervous system. Proc. natn. Acad. Sci. U.S.A. 85:1988;2839-2843.
15. Lauder J.M. Neurotransmitter as growth regulatory signals: role of receptors and second messengers. Trends Neurosci. 16:1993;233-240.
16. Lauder J.M., Liu J. Glial heterogeneity and developing neurotransmitter systems. Perspect. devl Neurobiol. 2:1994;239-250.
17. Lieb K., Andrae J., Reisert I., Pilgrim C. Neurotoxicity of dopamine and protective effects of the NMDA receptor antagonist AP-5 differ between male and female dopaminergic neurons. Expl Neurol. 134:1995;222-229.
18. Lindefors N., Brene S., Herrera-Marschitz M., Persson H. Region specific regulation of glutamic acid decarboxylase mRNA expression by dopamine neurons in rat brain. Expl Brain Res. 77:1989;611-620.
19. Lipton S.A., Kater S.B. Neurotransmitter regulation of neuronal outgrowth, plasticity and survival. Trends Neurosci. 12:1989;265-270.
20. Liu F.-C., Takahashi H., McKay R.D.G., Graybiel A.M. Dopaminergic regulation of transcription factor expression in organotypic cultures of developing striatum. J. Neurosci. 15:1995;2367-2384.
21. McCobb D.P., Haydon P.G., Kater S.B. Dopamine and serotonin inhibition of neurite elongation of different identified neurons. J. Neurosci. Res. 19:1988;19-26.
22. McCobb D.P., Kater S.B. Membrane voltage and neurotransmitter regulation of neuronal growth cone motility. Devl Biol. 130:1988;599-609.
23. Meredith G.E., Ypma P., Zahm D.S. Effects of dopamine depletion on the morphology of medium spiny neurons in the shell and core of the rat nucleus accumbens. J. Neurosci. 15:1995;3808-3820.
24. Morgan J.I., Curran T. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. A. Rev. Neurosci. 14:1991;421-451.
25. Oestreicher A.B., Van Dongen C.J., Zwiers H., Gispen W.H. Affinity-purified anti-B-50 protein antibody: interference with the function of the phosphoprotein B-50 in synaptic plasma membranes. J. Neurochem. 41:1983;331-340.
26. Perrone-Bizzozero N.I., Finklestein S.P., Benowitz L.I. Synthesis of a growth-associated protein by embryonic rat cerebrocortical neurons in vitro. J. Neurosci. 6:1986;3721-3730.
27. Ramakers G.J.A., Oestreicher A.B., Wolters P.S., Van Leeuwen F.W., De Graan P.N.E., Gispen W.H. Developmental changes in B-50 (GAP-43) in primary cultures of cerebral cortex: B-50 immunolocalization, axonal elongation rate and growth cone morphology. Int. J. devl Neurosci. 9:1991;215-230.
28. Reisert I., Schuster R., Zienecker R., Pilgrim C. Prenatal development of mesencephalic and diencephalic dopaminergic systems in the male and female rat. Devl Brain Res. 53:1990;222-229.
29. 2 dopamine receptor subtypes in rat brain using in situ hybridization and receptor binding. Neuroscience. 62:1994;65-85.
30. Schilling K., Luk D., Curran T., Morgan J.I. Regulation of a fos-lacZ fusion gene: a paradigm for quantitative analysis of stimulus-secretion coupling. Proc. natn. Acad. Sci. U.S.A. 88:1991;5665-5669.
31. Schwartz J.P. Neurotransmitters as neurotrophic factors: a new set of functions. Int. Rev. Neurobiol. 34:1992;1-24.
32. Simpson C.S., Johnston H.M., Morris B.J. Phenotypic characterization of rat striatal neurones in primary culture. Tissue Cell. 26:1994;929-941.
33. 1-like dopamine receptors, involves protein kinase A and protein kinase C. Neuroscience. 68:1995;97-106.
34. Sivam S.P., Krause J.E., Breese G.R., Hong J.-S. Dopamine-dependent postnatal development of enkephalin and tachykinin neurons of rat basal ganglia. J. Neurochem. 56:1991;1499-1508.
35. Surmeier D.J., Reiner A., LeVine M.S., Ariano M.A. Are neostriatal dopamine receptors co-localized? Trends Neurosci. 16:1993;299-305.
36. 4 dopamine receptors revealed in transfected neuronal cell lines. Proc. natn. Acad. Sci. U.S.A. 91:1994;649-653.
37. Todd R.D. Neural development is regulated by classical neurotransmitters: dopamine D2 receptor stimulation enhances neurite outgrowth. Biol. Psychiat. 31:1992;794-807.
38. Van Hooff C.O.M., Holthuis J.C.M., Oestreicher A.B., Boonstra J., De Graan P.N.E., Gispen W.H. Nerve growth factor-induced changes in the intracellular localization of the protein kinase C substrate B-50 in pheochromocytoma PC12 cells. J. Cell Biol. 108:1989;1115-1125.
39. Wilson C. J. (1990) Basal ganglia. In The Synaptic Organization of the Brain (ed. Shepherd G. M.), pp. 279-316. Oxford University Press, New York.
40. Xu M., Moratalla R., Gold L.H., Hiroi N., Koob G.F., Graybiel A.M., Tonegawa S. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell. 79:1994;729-742.
41. Young W.S., Bonner T.I., Brann M.R. Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc. natn. Acad. Sci. U.S.A. 83:1986;9827-9831.